chr17-31258376-C-G

Variant summary

Our verdict is Uncertain significance.
+4 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 4 classification points (ACMG Germline Pathogenicity v2019). PM1_SupportingPM2PP3

The NM_001042492.3(NF1):c.4206C>G (p.Ile1402Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.I1402F: Uncertain_significance (ClinVar VariationId 1738171, 2 stars); p.I1402= (synonymous): Benign/Likely_benign (ClinVar VariationId 220165, 2 stars); p.I1402V: Uncertain_significance (ClinVar VariationId 3404946, 2 stars)

Frequency

Genomes: not found (cov: 32)

Consequence

NF1
NM_001042492.3 missense

Scores

3
14
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.182

Publications

3 publications found
Variant links:
Genes affected
NF1 (HGNC:7765): (neurofibromin 1) This gene product appears to function as a negative regulator of the ras signal transduction pathway. Mutations in this gene have been linked to neurofibromatosis type 1, juvenile myelomonocytic leukemia and Watson syndrome. The mRNA for this gene is subject to RNA editing (CGA>UGA->Arg1306Term) resulting in premature translation termination. Alternatively spliced transcript variants encoding different isoforms have also been described for this gene. [provided by RefSeq, Jul 2008]
NF1 Gene-Disease associations (from GenCC):
  • neurofibromatosis type 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen, G2P, Genomics England PanelApp
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Moyamoya disease
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001042492.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 4 points.

PM1Mutational hot spot or critical domain
Missense neighbourhood moderate hotspot (≥2 P/LP within ±8 AA, OR ≥ 2 vs. background) — PM1 supporting; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 2 pathogenic, 3 benign (OR vs. background: 3.6).
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD/XL) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.00122) — PM2 moderate.
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001042492.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
NM_001042492.3
MANE Select
c.4206C>Gp.Ile1402Met
missense
Exon 32 of 58NP_001035957.1P21359-1
NF1
NM_000267.4
c.4143C>Gp.Ile1381Met
missense
Exon 31 of 57NP_000258.1P21359-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NF1
ENST00000358273.9
TSL:1 MANE Select
c.4206C>Gp.Ile1402Met
missense
Exon 32 of 58ENSP00000351015.4P21359-1
NF1
ENST00000356175.7
TSL:1
c.4143C>Gp.Ile1381Met
missense
Exon 31 of 57ENSP00000348498.3P21359-2
NF1
ENST00000579081.6
TSL:1
n.4143C>G
non_coding_transcript_exon
Exon 31 of 58ENSP00000462408.2J3KSB5

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:32
GnomAD4 exome
Cov:31
GnomAD4 genome
Cov:32
Showing 3 sources

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype (1)

Computational Scores

AlphaGenome AVI
Pathogenic21
AlphaMissense
Benign0.23
BayesDel_addAF
Pathogenic0.22D
BayesDel_noAF
Uncertain0.070
CADD
Benign21
DANN
Uncertain1.0
DEOGEN2
Uncertain0.66D
Eigen
Uncertain0.29
Eigen_PC
Uncertain0.27
FATHMM_MKL
Uncertain0.86D
FuncVEP CTI
Benign0.086
GPN-Star LLR
N/A-9.1
GPN-Star score
N/A9.1
LIST_S2
Uncertain0.93D
M_CAP
Pathogenic0.85D
MetaRNN
Uncertain0.72D
MetaSVM
Uncertain0.15D
Mutation Taster
N/A20/80disease causing
MutationAssessor
Uncertain2.1M
PhyloP100
Benign0.18
PrimateAI
Uncertain0.73T
PROVEAN
Benign-1.7N
REVEL
Pathogenic0.65
Sift
Uncertain0.0040D
Sift4G
Uncertain0.018D
Varity_R
N/A0.87
VESM-3B
Benign-8.0
Showing 27 of 27 scores

Splicing Scores

Pangolin (max)
Benign0.040
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.